Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Jul 15, 2020; 12(7): 705-718
Published online Jul 15, 2020. doi: 10.4251/wjgo.v12.i7.705
Published online Jul 15, 2020. doi: 10.4251/wjgo.v12.i7.705
Table 1 2010 World Health Organization grading classification of gastroenteropancreatic neuroendocrine neoplasms
| Classification/grade | Mitotic index (per 10 HPF) | Ki67 index (%) |
| G1 (NET G1) | < 2 | < 2 |
| G2 (NET G2) | 2-20 | 2-20 |
| G3 (NEC) | > 20 | > 20 |
Table 2 2017 World Health Organization grading classification of pancreatic neuroendocrine neoplasms
| Classification/grade | Mitotic index (per 10 HPF) | Ki67 index (%) |
| pNET | ||
| G1 | < 3 | < 3 |
| G2 | 3–20 | 3–20 |
| G3 | > 20 | > 20 |
| pNEC | ||
| Small cell type | > 20 | > 20 |
| Large cell type | > 20 | > 20 |
- Citation: Zhang MY, He D, Zhang S. Pancreatic neuroendocrine tumors G3 and pancreatic neuroendocrine carcinomas: Differences in basic biology and treatment. World J Gastrointest Oncol 2020; 12(7): 705-718
- URL: https://www.wjgnet.com/1948-5204/full/v12/i7/705.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i7.705